REPORT SCOPE
INTRODUCTION
REASON FOR THE STUDY
Among the significant forces that continue to affect the global excipients industry in 2011 are a crisis in the global supply chain, the demands of Quality by Design (QbD), and worries about drug safety. Positive trends include the development of creative ideas in response to the need for new excipients and new levels of cooperation between major players (e.g., Dow and Colorcon). These forces are reshaping the global market for excipients.
GOALS AND OBJECTIVES
The primary goals of this technical/market report are to provide a detailed analysis of the current excipients market and a forecast of what the market will look like in 5 years. The specific objectives are (1) identify excipients being used; (2) quantify global market volume; (3) track important developments; (4) analyze the structure of the industry and its driving forces; (5) examine the most active companies and describe how they respond to market demands; and (6) provide data with which the reader can further evaluate the industry.
AUDIENCE
As a market and technology summary, this report consolidates a wide range of industrial and technical information that should aid excipient suppliers, chemical companies, drug manufacturers, healthcare regulators, and congressional staffers to stay current with today’s market. The report should be of value to companies interested in entering or expanding their involvement in the field. The report should provide senior marketing personnel and executive planners with insight about what materials can best satisfy customer demands. Market projections may be of interest to venture capitalists interested in exploring commercialization opportunities, as well as companies and personnel involved in designing and constructing chemical and excipient manufacturing plants and/or those who service such plants. The report offers useful background to consultants in the field. The report can serve as an introductory resource for newcomers to the business, including new employees. In addition, the report can offer background to governmental officials examining reform.
SCOPE OF REPORT
Excipients in Pharmaceuticals offers coverage of the most important issues surrounding excipients: technological, regulatory, economic, and political issues, and so on.
Excluded from the study are ingredients for cosmetics, personal care, food, quasi-medical, unorthodox, alternative, home remedies, underground and/or illegal drugs, and veterinary drugs.
This report organizes information from diverse sources into sections entitled Summary, Overview, Technology, Industry Structure, and Company Profiles. The Summary encapsulates several key conclusions and includes a table of market findings. The Overview provides deep background information on the most important issues of the day, including the global supply chain crisis, QbD, and legislative prospects. The Technology section examines excipients by chemical compounds, functional uses, and delivery systems, and as finished products. The Industry Structure section discusses the market environment, strategies, influences, market shares, international aspects, and other related factors. The Company Profiles segment provides summaries of more than 120 companies that supply excipients or are relevant to the industry.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this study. The methodology used to create Excipients in Pharmaceuticals included extensive telephone interviews with key executives of leading U.S. and European companies and consultancies. This commentary was combined with information gleaned from websites, annual reports, the trade press, textbooks, patents, press releases, and government documents.
The information has been used to project and forecast market size, and calculate compound annual growth rates (CAGRs) of the overall market and many market segments. All market sizes refer to worldwide values and volumes, which are rounded to the nearest million in dollars and pounds. Market size is estimated at the manufacturer level; that is, the level of consumption in actual drug formulations. Where precise information was not available, a consensus was made using a formulation of reasonable assumptions and estimates based on historical data. In this report, the market size for 2010 serves as a basis for making estimates for 2011 and projections to 2016.
ANALYST CREDENTIALS
Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of several previous BCC reports on various aspects of the pharmaceutical marketplace as well as analyses of major trends and the pharmaceutical regulatory environment.
BCC ONLINE SERVICES
BCC offers online services at bccresearch.com. Readers can:
- Examine BCC’s complete catalog of Market Research Reports, and place orders.
- Subscribe to BCC’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for BCC’s well-known conferences.
- Request additional information on BCC products.
- Take advantage of special offers.
DISCLAIMER
The information in this report is intended to be as reliable as possible at the time of publication. This information does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or laboratory manual, nor as an endorsement of any product. The information here is developed carefully from informed sources, but much of it is speculative in nature. The author and publisher assume no responsibility for any loss or damage that might result from use or reliance on information in this report.
